Biotechnology

IND clearance positions SER-252 for clinical progress in advanced Parkinson’s disease treatment Serina Therapeutics (SER) announced a significant regulatory milestone...

While “AI-discovered” breakthrough medicines are still emerging, pharma is using AI today to cut costs, speed trials, and reduce regulatory...

Deal delivers global rights to experimental food allergy therapy ozureprubart as GSK pursues growth under new CEO Luke Miels. Britain’s...

Transformative deal targets the biological roots of autism, opening a new frontier in disease-modifying therapy. XTL Biopharmaceuticals has taken a...

Envudeucitinib positions the biotech for a high-stakes TYK2 showdown heading into 2026 Biotech stock Alumis (ALMS) surged more than 110%...

Strong LINZESS growth, rising profitability, and pipeline progress underpin confidence despite pricing changes Ironwood Pharmaceuticals (IRWD) entered 2026 with a...

Omeros secures landmark approval for a life-saving therapy in adults and children following stem cell transplant The U.S. Food and...

NGC-Cap shows enhanced cancer-killing exposure with comparable safety ahead of 2026 interim analysis Processa Pharmaceuticals (PCSA) provided a positive clinical...

Earnings guidance, analyst calls, and commodity moves drive sharp stock reactions U.S. stocks delivered a mixed performance Tuesday as investors...

Lower demand for pandemic-era products weighs on earnings and revenue forecasts Pfizer (PFE) shares edged lower in premarket trading on...